• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物基因组学中细胞毒性图谱关联方法的比较

A comparison of association methods for cytotoxicity mapping in pharmacogenomics.

作者信息

Brown Chad, Havener Tammy M, Everitt Lorraine, McLeod Howard, Motsinger-Reif Alison A

机构信息

Department of Statistics, North Carolina State University Raleigh, NC, USA.

出版信息

Front Genet. 2011 Dec 14;2:86. doi: 10.3389/fgene.2011.00086. eCollection 2011.

DOI:10.3389/fgene.2011.00086
PMID:22303380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3268638/
Abstract

Cytotoxicity assays of immortalized lymphoblastoid cell lines (LCLs) represent a promising new in vitro approach in pharmacogenomics research. However, previous studies employing LCLs in gene mapping have used simple association methods, which may not adequately capture the true differences in non-linear response profiles between genotypes. Two common approaches summarize each dose-response curve with either the IC50 or the slope parameter estimates from a hill slope fit and treat these estimates as the response in a linear model. The current study investigates these two methods, as well as four novel methods, and compares their power to detect differences between the response profiles of genotypes under a variety of different alternatives. The four novel methods include two methods that summarize each dose-response by its area under the curve, one method based off of an analysis of variance (ANOVA) design, and one method that compares hill slope fits for all individuals of each genotype. The power of each method was found to depend not only on the choice of alternative, but also on the choice for the set of dosages used in cytotoxicity measurements. The ANOVA-based method was found to be the most robust across alternatives and dosage sets for power in detecting differences between genotypes.

摘要

永生化淋巴母细胞系(LCLs)的细胞毒性测定是药物基因组学研究中一种很有前景的新体外方法。然而,先前在基因定位中使用LCLs的研究采用的是简单关联方法,可能无法充分捕捉不同基因型之间非线性反应谱的真实差异。两种常见方法分别用半数抑制浓度(IC50)或根据希尔斜率拟合得到的斜率参数估计值来总结每条剂量反应曲线,并将这些估计值作为线性模型中的反应。本研究对这两种方法以及四种新方法进行了研究,并比较了它们在各种不同替代情况下检测基因型反应谱差异的能力。这四种新方法包括两种通过曲线下面积总结每条剂量反应的方法、一种基于方差分析(ANOVA)设计的方法以及一种比较每种基因型所有个体的希尔斜率拟合的方法。发现每种方法的能力不仅取决于替代方案的选择,还取决于细胞毒性测量中所用剂量组的选择。基于方差分析的方法在检测基因型差异的能力方面,在各种替代方案和剂量组中最为稳健。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/a49cc2c8b0a4/fgene-02-00086-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/eefefcb00ac3/fgene-02-00086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/a8961cf306ba/fgene-02-00086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/a3622763a10e/fgene-02-00086-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/2a336309f03b/fgene-02-00086-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/17cd9a9ab3ad/fgene-02-00086-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/e439f678e4a0/fgene-02-00086-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/8ba8a33ebed2/fgene-02-00086-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/5782db62edf4/fgene-02-00086-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/a49cc2c8b0a4/fgene-02-00086-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/eefefcb00ac3/fgene-02-00086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/a8961cf306ba/fgene-02-00086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/a3622763a10e/fgene-02-00086-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/2a336309f03b/fgene-02-00086-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/17cd9a9ab3ad/fgene-02-00086-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/e439f678e4a0/fgene-02-00086-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/8ba8a33ebed2/fgene-02-00086-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/5782db62edf4/fgene-02-00086-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec25/3268638/a49cc2c8b0a4/fgene-02-00086-g009.jpg

相似文献

1
A comparison of association methods for cytotoxicity mapping in pharmacogenomics.药物基因组学中细胞毒性图谱关联方法的比较
Front Genet. 2011 Dec 14;2:86. doi: 10.3389/fgene.2011.00086. eCollection 2011.
2
Multivariate methods and software for association mapping in dose-response genome-wide association studies.多变量方法和软件在剂量反应全基因组关联研究中的关联映射。
BioData Min. 2012 Dec 12;5(1):21. doi: 10.1186/1756-0381-5-21.
3
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines.利用淋巴母细胞系对29种抗癌药物进行全基因组关联分析和药理学分析。
Pharmacogenomics. 2014 Feb;15(2):137-46. doi: 10.2217/pgs.13.213.
4
Ex-Vivo Modeling for Heritability Assessment and Genetic Mapping in Pharmacogenomics.药物基因组学中用于遗传力评估和基因定位的体外建模
Proc Am Stat Assoc. 2011 Jul-Aug;2011:306-318.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.辐射药效基因组学:一种全基因组关联方法,用于使用人淋巴母细胞系鉴定辐射反应生物标志物。
Genome Res. 2010 Nov;20(11):1482-92. doi: 10.1101/gr.107672.110. Epub 2010 Oct 5.
7
Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.二甲双胍药物基因组学:一项全基因组关联研究,旨在利用人淋巴母细胞系鉴定参与二甲双胍抗癌反应的遗传和表观遗传生物标志物。
Hum Mol Genet. 2016 Nov 1;25(21):4819-4834. doi: 10.1093/hmg/ddw301.
8
A Novel Lack-of-Fit Assessment as a System Suitability Test for Potency Assays.一种作为效价测定系统适用性测试的新型失拟评估方法。
PDA J Pharm Sci Technol. 2017 Sep-Oct;71(5):368-378. doi: 10.5731/pdajpst.2016.007369. Epub 2017 Jun 16.
9
Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines.协同化疗药物反应是淋巴母细胞系中的一种遗传特性。
Front Genet. 2019 Oct 15;10:829. doi: 10.3389/fgene.2019.00829. eCollection 2019.
10
A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity.一种用于评估基因变异与药物细胞毒性之间关联的贝叶斯分层非线性模型。
Stat Med. 2009 Sep 20;28(21):2709-22. doi: 10.1002/sim.3649.

引用本文的文献

1
Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics.来自牡蛎血淋巴的抗菌蛋白可提高传统抗生素的疗效。
PLoS One. 2025 Jan 21;20(1):e0312305. doi: 10.1371/journal.pone.0312305. eCollection 2025.
2
A Methodological Framework to Discover Pharmacogenomic Interactions Based on Random Forests.基于随机森林的药物基因组学相互作用发现的方法学框架。
Genes (Basel). 2021 Jun 18;12(6):933. doi: 10.3390/genes12060933.
3
Chemical Synthesis Enables Structural Reengineering of Aglaroxin C Leading to Inhibition Bias for Hepatitis C Viral Infection.

本文引用的文献

1
Ex-Vivo Modeling for Heritability Assessment and Genetic Mapping in Pharmacogenomics.药物基因组学中用于遗传力评估和基因定位的体外建模
Proc Am Stat Assoc. 2011 Jul-Aug;2011:306-318.
2
Optimization of nonlinear dose- and concentration-response models utilizing evolutionary computation.利用进化计算优化非线性剂量-浓度反应模型。
Dose Response. 2011;9(3):387-409. doi: 10.2203/dose-response.09-030.Beam. Epub 2010 Jun 25.
3
Pharmacogenomic characterization of US FDA-approved cytotoxic drugs.美国食品和药物管理局批准的细胞毒药物的药物基因组学特征。
化学合成使 Aglaroxin C 的结构重工程成为可能,导致对丙型肝炎病毒感染的抑制偏向。
J Am Chem Soc. 2019 Jan 23;141(3):1312-1323. doi: 10.1021/jacs.8b11477. Epub 2019 Jan 11.
4
Identifying genes that mediate anthracyline toxicity in immune cells.鉴定介导蒽环类药物在免疫细胞中产生毒性的基因。
Front Pharmacol. 2015 Apr 15;6:62. doi: 10.3389/fphar.2015.00062. eCollection 2015.
5
Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics.基于免疫细胞的抗癌药物反应筛选测定法:在药物基因组学中的应用
Pharmgenomics Pers Med. 2015 Feb 26;8:81-98. doi: 10.2147/PGPM.S73312. eCollection 2015.
6
An investigation of gene-gene interactions in dose-response studies with Bayesian nonparametrics.贝叶斯非参数在剂量-反应研究中基因-基因交互作用的研究
BioData Min. 2015 Feb 6;8:6. doi: 10.1186/s13040-015-0039-3. eCollection 2015.
7
Beyond IC: Towards Robust Statistical Methods for Association Studies.超越全基因组关联研究:迈向关联研究的稳健统计方法
J Pharmacogenomics Pharmacoproteomics. 2014 Mar 1;5(1):1000121. doi: 10.4172/2153-0645.1000121.
8
Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.药物反应的淋巴母细胞样细胞系模型:该药物基因组学模型的成功与经验教训。
Curr Mol Med. 2014;14(7):833-40. doi: 10.2174/1566524014666140811113946.
9
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines.利用淋巴母细胞系对29种抗癌药物进行全基因组关联分析和药理学分析。
Pharmacogenomics. 2014 Feb;15(2):137-46. doi: 10.2217/pgs.13.213.
10
Genetic and epigenetic variants contributing to clofarabine cytotoxicity.导致氯法拉滨细胞毒性的遗传和表观遗传变异。
Hum Mol Genet. 2013 Oct 1;22(19):4007-20. doi: 10.1093/hmg/ddt240. Epub 2013 May 29.
Pharmacogenomics. 2011 Oct;12(10):1407-15. doi: 10.2217/pgs.11.92.
4
Genomic profiling in CEPH cell lines distinguishes between the camptothecins and indenoisoquinolines.在 CEPH 细胞系中进行基因组分析可区分喜树碱类和吲哚异喹啉类。
Mol Cancer Ther. 2011 Oct;10(10):1839-45. doi: 10.1158/1535-7163.MCT-10-0872. Epub 2011 Jul 12.
5
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.基于细胞的方法发现铂类药物敏感性相关种系多态性及其与卵巢癌患者结局的相关性分析。
Clin Cancer Res. 2011 Aug 15;17(16):5490-500. doi: 10.1158/1078-0432.CCR-11-0724. Epub 2011 Jun 24.
6
Identification and replication of loci involved in camptothecin-induced cytotoxicity using CEPH pedigrees.利用 CEPH 家系鉴定和复制喜树碱诱导细胞毒性相关的基因座。
PLoS One. 2011 May 5;6(5):e17561. doi: 10.1371/journal.pone.0017561.
7
Cell-based Models for Discovery of Pharmacogenomic Markers of Anticancer Agent Toxicity.用于发现抗癌药物毒性的药物基因组学标志物的细胞模型
Trends Cancer Res. 2008;4:1-13.
8
PACdb: a database for cell-based pharmacogenomics.PACdb:一个基于细胞的药物基因组学数据库。
Pharmacogenet Genomics. 2010 Apr;20(4):269-73. doi: 10.1097/FPC.0b013e328337b8d6.
9
Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.遗传和非遗传因素作为淋巴母细胞系药物表型的变量。
Pharmacogenomics J. 2010 Dec;10(6):505-12. doi: 10.1038/tpj.2010.3. Epub 2010 Feb 9.
10
Pharmacogenomic discovery using cell-based models.基于细胞模型的药物基因组学发现。
Pharmacol Rev. 2009 Dec;61(4):413-29. doi: 10.1124/pr.109.001461.